References
- Abe R., Peng T., Sailors J., Bucala R., Metz C.N.: Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 2001, 166, 747–753.
- Barrow A.D., Burgess S.C., Baigent S.J., Howes K., Nair V.K.: Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek’s disease virus. J Gen Virol 2003, 84, 2635–2645.
- Biggs P.M.: The history and biology of Marek’s disease virus. Curr Top Microbiol Immunol 2001, 255, 1–24.
- Calandra T., Roger T.: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3, 791–800.
- Chuang Y.C., Lei H.Y., Liu H.S., Lin Y.S., Fu T.F., Yeh T.M.: Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine 2011, 54, 222–231.
- Frascaroli G., Varani S., Blankenhorn N., Pretsch R., Bacher M., Leng L., Bucala R., Landini M.P., Mertens T.: Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J Immunol 2009, 182, 477–488.
- Gimeno I.M., Witter R.L., Hunt H.D., Lee L.F., Reddy S.M., Neumann U.: Marek’s disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression. Vet Pathol 2001, 38, 491–503.
- Hu X., Qin A., Miao J., Xu W., Yu C., Qian K., Shao H.: Transcriptional profile of Marek’s disease virus genes in chicken thymus during different phases of MDV infection. Arch Virol 2013, 158, 1787–1793.
- Hu X., Qin A., Qian K., Shao H., Yu C., Xu W., Miao J.: Analysis of protein expression profiles in the thymus of chickens infected with Marek’s disease virus. Virol J 2012, 9, 1–18.
- Hu X., Xu W., Qin A., Wu G., Qian K., Shao H., Ye J.: Marek’s disease virus may interfere with T cell immunity by TLR3 signals. Vet Res Commun 2014, 38, 149–156.
- Jung H., Seong H.A., Ha H.: Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 2008, 283, 20383–20396.
- Kim S., Miska K.B., Jenkins M.C., Fetterer R.H., Cox C.M., Stuard L.H., Dalloul R.A.: Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF). Dev Comp Immunol 2010, 34, 1021–1032.
- Laursen A.M.S., Kulkarni R.R., Taha-Abdelaziz K., Plattner B.L., Read L.R., Sharif S.: Characterizaton of gamma delta T cells in Marek’s disease virus (Gallid herpesvirus 2) infection of chickens. Virology 2018, 522, 56–64.
- Levy A.M., Davidson I., Burgess S.C., Heller E.D.: Major histocompatibility complex class I is downregulated in Marek’s disease virus infected chicken embryo fibroblasts and corrected by chicken interferon. Comp Immunol Microbiol Infect Dis 2003, 26, 189–198.
- Li Y.P., Bang D.D., Handberg K.J., Jorgensen P.H., Zhang M.F.: Evaluation of the suitability of six host genes as internal control in real-time RT-PCR assays in chicken embryo cell cultures infected with infectious bursal disease virus. Vet Microbiol 2005, 110, 155–165.
- Mantovani A., Allavena P., Sica A., Balkwill F.: Cancer-related inflammation. Nature 2008, 454, 436–444.
- Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., David J., Bucala R.: Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002, 99, 345–350.
- Miyazaki D., Haruki T., Takeda S., Sasaki S., Yakura K., Terasaka Y., Komatsu N., Yamagami S., Touge H., Touge C., Inoue Y.: Herpes simplex virus type 1-induced transcriptional networks of corneal endothelial cells indicate antigen presentation function. Invest Ophthalmol Vis Sci 2011, 52, 4282–4293.
- Nobre C.C., de Araújo J.M., Fernandes T.A., Cobucci R.N., Lanza D.C., Andrade V.S., Fernandes J.V.: Macrophage migration inhibitory factor (MIF): biological activities and relation with cancer. Pathol Oncol Res 2017, 23, 235–244.
- Oda S., Oda T., Nishi K., Takabuchi S., Wakamatsu T., Tanaka T., Adachi T., Fukuda K., Semenza G.L., Hirota K.: Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One 2008, 3, e2215.
- Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., Trapp S.: Marek’s disease virus: from miasma to model. Nat Rev Microbiol 2006, 4, 283–294.
- Regis E.G., Barreto-de-Souza V., Morgado M.G., Bozza M.T., Leng L., Bucala R., Bou-Habib D.C.: Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication. Virology 2010, 399, 31–38.
- Schinagl A., Thiele M., Douillard P., Völkel D., Kenner L., Kazemi Z., Freissmuth M., Scheiflinger F., Kerschbaumer R.J.: Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer. Oncotarget 2016, 7, 73486–73496.
- Yan X., Orentas R.J., Johnson B.D.: Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation. Cytokine 2006, 33, 188–198.
- Zhou Q., Yan X., Gershan J., Orentas R.J., Johnson B.D.: Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo J Immunol 2008, 181, 1877–1886.